C2A Security is the only context driven and AI powered product security vendor purpose built to address the cybersecurity, safety, and regulatory needs of medical device manufacturers and healthcare delivery organizations. Founded in 2016, C2A Security helps regulated industries transform cybersecurity from a compliance burden into a strategic enabler of innovation and patient safety. C2A Security strengthened its medical device leadership through the acquisition of Vigilant Ops, expanding its expertise in medical device cybersecurity risk management and regulatory alignment.
Through its EVSec platform, C2A Security leverages AI driven automation to orchestrate product cybersecurity risk management across devices and connected clinical environments. By linking threats, vulnerabilities, SBOM intelligence, requirements, and releases into a contextual risk model, organizations move beyond checklist compliance toward defensible, auditable, data driven risk management aligned with FDA QMSR and global medical regulations.
Our vision is to make product security intelligent, automated, and transparent, reducing time to market, lowering remediation costs, and strengthening resilience across the healthcare ecosystem.
Founded by NDS and Cisco veteran Michael Dick, C2A Security is headquartered in Jerusalem, Israel.
